FDA Advisory Panel Votes in Support of Cystic Fibrosis Drug

Drug Industry Daily
A A
An FDA advisory committee voted Wednesday in favor of Chiesi’s Bronchitol (inhaled mannitol) for improving lung function in cystic fibrosis patients aged 18 and older.

To View This Article:

Login

Subscribe To Drug Industry Daily